Gentamicin 80 mg/2 mL Injection BP

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

gentamicin sulfate, Quantity: 40 mg/mL

Disponível em:

Pfizer (Perth) Pty Ltd

DCI (Denominação Comum Internacional):

gentamicin sulfate

Forma farmacêutica:

Injection, solution

Composição:

Excipient Ingredients: disodium edetate; sulfuric acid; sodium hydroxide; water for injections

Via de administração:

Intramuscular, Intravenous

Unidades em pacote:

2 mL x 50, 2 mL x 10

Tipo de prescrição:

(S1) This Schedule is intentionally blank

Indicações terapêuticas:

For treatment of infections due to one or more susceptible strains of bacteria, including Pseudomonas aeruginosa, Proteus species (indole positive and indole negative), Escherichia coli, Klebsiella, Enterobacter and Serratia species and Staphylococcus (including strains resistant to other antibiotics). Gentamicin may also be used for the treatment of the following conditions when caused by susceptible organisms: bacteraemia, respiratory tract infections, urinary tract infections, skin and skin structure infections, bone infections, peritonitis, septic abortion and burns complicated by sepsis.

Resumo do produto:

Visual Identification: A clear pale yellow aqueous solution, practically free from visible particles; Container Type: Ampoule; Container Material: LDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Licence status A

Data de autorização:

2016-08-01